The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Adiponectin and Breast Cancer Risk
Abstract
Adiponectin, an adipocyte-secreted hormone, is closely and inversely associated with insulin resistance and was recently found to be inversely and independently associated with endometrial cancer. Because insulin resistance in the setting of obesity has also been associated with the development of breast cancer, we have hypothesized that decreased adiponectin levels might underlie the association between breast cancer and obesity/insulin resistance. We evaluated the association of adiponectin with the occurrence of breast cancer in a case-control study comprising 174 women with newly diagnosed, histologically confirmed breast cancer and 167 controls. We found an inverse, fairly strong, and statistically significant association of serum adiponectin with breast cancer (odds ratio, 0.84; 95% confidence interval, 0.71-0.99). Importantly, despite a fairly robust inverse association of adiponectin with breast cancer risk among postmenopausal women (odds ratio, 0.82; 95% confidence interval, 0.67-1.00), no such significant association between adiponectin and breast cancer was found among premenopausal women. The observed associations were independent of possible effects of major components of the IGF system, leptin, body mass index, sociodemographic variables, and known risk factors for breast cancer. Future studies are needed to prove causality and provide further insights into both the mechanisms underlying the actions of this hormone and its potential role in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk
van den Brandt, P. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.6.514 · Cited by 1,023
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plasma
Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T., & Tomita, M. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021483 · Cited by 916
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103241200 · Cited by 637
Stefan, N., Vozarova, B., Funahashi, T., Matsuzawa, Y., Weyer, C., Lindsay, R. S., Youngren, J. F., Havel, P. J., Pratley, R. E., Bogardus, C., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1884 · Cited by 558
YAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T. (2002) · Clinical Science · doi:10.1042/cs1030137 · Cited by 490
Gavrila, A., Chan, J. L., Yiannakouris, N., Kontogianni, M., Miller, L. C., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030214 · Cited by 441
Self-citationBachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
Kaleko, M., Rutter, W. J., & Miller, A. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.464 · Cited by 409
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Self-citationInsulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study
Michels, K. B., Solomon, C. G., Hu, F. B., Rosner, B. A., Hankinson, S. E., Colditz, G. A., & Manson, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1752 · Cited by 341
Insulin and related factors in premenopausal breast cancer risk
Del Giudice, M. E., Fantus, I. G., Ezzat, S., McKeown-Eyssen, G., Page, D., & Goodwin, P. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005831013718 · Cited by 304
Plasma Adiponectin Concentrations in Children: Relationships with Obesity and Insulinemia
Stefan, N., Bunt, J. C., Salbe, A. D., Funahashi, T., Matsuzawa, Y., & Tataranni, P. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020694 · Cited by 293
van der Burg, B., Rutteman, G. R., Blankenstein, M. A., de Laat, S. W., & van Zoelen, E. J. J. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340112 · Cited by 247
Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece
Petridou, E., Mantzoros, C., Dessypris, N., Koukoulomatis, P., Addy, C., Voulgaris, Z., Chrousos, G., & Trichopoulos, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021209 · Cited by 234
Self-citationBruning, P. F., Van Doorn, J., Bonfrèr, J. M. G., Van Noord, P. A. M., Korse, C. M., Linders, T. C., & Hart, A. A. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620306 · Cited by 210
Insulin receptor expression and function in human breast cancer cell lines.
Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., & Belfiore, A. (1992) · PubMed · Cited by 206
Risk of endometrial and breast cancer in patients with diabetes mellitus
Weiderpass, E., Gridley, G., Persson, I., Nyrén, O., Ekbom, A., & Adami, H.-O. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<360::aid-ijc9>3.0.co;2-w · Cited by 186
Cleary, M. P., & Maihle, N. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44153b · Cited by 167
Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells
Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 167
Western nutrition and the insulin resistance syndrome: A link to breast cancer
Stoll, B. A. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600700 · Cited by 130
Mink, P. J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf050 · Cited by 126
Leptin and Body Mass Index in Relation to Endometrial Cancer Risk
Petridou, E. T., Belechri, M., Dessypris, N., Koukoulomatis, P., Diakomanolis, E., Spanos, E., & Trichopoulos, D. (2002) · Annals of Nutrition and Metabolism · doi:10.1159/000063081 · Cited by 113
Self-citationJernström, H., & Barrett-Connor, E. L. (1999) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/jwh.1.1999.8.1265 · Cited by 106
White Adipocyte Vascular Endothelial Growth Factor: Regulation by Insulin
Mick, G. J., Wang, X., & McCormick, K. L. (2002) · Endocrinology · doi:10.1210/endo.143.3.8673 · Cited by 103
Upper abdominal obesity, insulin resistance and breast cancer risk
Stoll, B. A. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801998 · Cited by 96
Insulin resistance: the clinical spectrum.
Mantzoros, C. S., & Flier, J. S. (1995) · PubMed · Cited by 95
Self-citationLai, A. K. W., Šarčević, B., Prall, O. W. J., & Sutherland, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100925200 · Cited by 93
Endometrial Cancer and the IGF System: A Case-Control Study in Greece
Petridou, E. T., Koukoulomatis, P., Alexe, D. M., Voulgaris, Z., Spanos, E., & Trichopoulos, D. (2003) · Oncology · doi:10.1159/000070291 · Cited by 68
Self-citation
Cited by
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Self-citationChildhood obesity and adult morbidities
Biro, F. M., & Wien, M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28701b · Cited by 1,096
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
The Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
Self-citation
Metadata
- Authors
- Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., & Trichopoulos, D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1102-1107
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2167596697
- Cited by
- 533
- References
- 37
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.